| In millions, except per share items | Mar-31-22 | Dec-31-21 |
| | 10-Q | 10-K |
| Cash Flows from Operating Activities: | | |
| Net income (loss) | 19.7 | -1.7 |
| Adjustments to reconcile net income (loss) to net cash (used in) from operating activities: | | |
| Interest earned on Trust Account | | |
| Interest accrued on note payable | 0.0 | |
| Termination fee | -1.5 | |
| Change in fair value of warrant liabilities | -19.1 | |
| Excess of fair value over cash received for private placement warrants | | |
| Offering costs allocated to warrant issuance | | |
| Changes in current assets and current liabilities: | | |
| Prepaid assets | 0.2 | -0.4 |
| Due to Sponsor | 0.0 | |
| Accounts payable and accrued expenses | 0.4 | 1.0 |
| Net cash (used in) provided by operating activities | 0.0 | 0.4 |
| |
| Cash Flows from Investing Activities: | | |
| Proceeds from Trust account | 0.1 | |
| Net cash provided by (used in) investing activities | 0.1 | |
| Proceeds from Initial Public Offering, net of underwriting discount | | 347.0 |
| Proceeds from issuance of Private Placement Warrants | | 347.0 |
| Cash received for share receivable | | 347.0 |
| Net cash provided by financing activities | 1.8 | 346.8 |
| Net Change in Cash | -1.1 | 0.7 |
| |
| Non-cash investing and financing activities: | | |
| Accretion for Class A common stock subject to possible redemption | -0.1 | 33.6 |